⌘K

Login Start Free

Home/Filings/4/0001123292-19-000886

4//SEC Filing

Xu Stella 4

Accession 0001123292-19-000886

CIK 0001661059other

View on SEC.gov Company Profile

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 8:20 PM ET

Size

5.1 KB

Accession

0001123292-19-000886

Insider Transaction Report

Form 4

Period: 2019-06-13

NextCure, Inc.NXTC

Director

Transactions

Award
Stock Option (Right to Buy)
2019-06-13+22,000→ 22,000 total
Exercise: $15.57Exp: 2029-06-12→ Common Stock (22,000 underlying)

Footnotes (1)

[F1]The option vests in three equal annual installments beginning on June 13, 2020.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

NextCure, Inc.

CIK 0001661059

Entity typeother

Related Parties

1

filerCIK 0001728741

Filing Metadata

Form type: 4
Filed: Jun 16, 8:00 PM ET
Accepted: Jun 17, 8:20 PM ET
Size: 5.1 KB

View on SEC.gov